Managing Director & Partner
Gerd Wübbels leads Boston Consulting Group’s Frankfurt office, and is a core member of the firm’s Health Care and People & Organization practices. Gerd is an expert in the life sciences industry (pharma, biopharma, medtech, agriculture, etc.) and works with clients on a wide range of topics, including large scale transformations (particularly post-merger integration) and commercial operations.
Prior to joining BCG, Gerd was a senior manager at the Monitor Group where he worked with biopharma companies on blockbuster product launches, and commercial and marketing excellence engagements. He is a member of the board of directors of PhagoMed, a pre-clinical biotech company and owner of a small café and bakery in his hometown. He also invests in and serves as a coach and mentor for startups.
To succeed in the European market, small biotechs need to build a commercialization presence that reaches the maximum number of patients while managing the tradeoffs.
Biodiversity is being destroyed around the globe—with dire implications for business and society. Here’s how companies can protect local ecosystems and build competitive advantage.
Global biodiversity loss becomes an imperative for all of society. Find out about the immense value provided by our ecosystems, and what is needed to protect them.
The old innovation model at the big agricultural-input companies no longer works. To survive, they must go digital and focus on customer needs.
Launching an orphan treatment is more complicated than ever. Here’s how to successfully navigate the challenges.